3261 results
Keyword Alli Remove keyword
-
List item
Herbal medicinal product: Allii sativi bulbus (updated)
Allium sativum L., Garlic, F: Assessment finalised, Last updated: 02/05/2023Allii sativi bulbus Cough and … this information. Key facts Allii sativi bulbusGarlicAllium … review of the monograph on Allii sativi bulbus EMA/HMPC/187357/2023Draft … -
List item
Herbal medicinal product: Allii cepae bulbus
Allium cepa L., Onion, F: Assessment finalised, Last updated: 29/05/2012Allii cepae bulbus … will be prepared. Key facts Allii cepae bulbusOnionAllium cepa … Final assessment report on Allium cepa L., bulbus EMA/HMPC/347195/2011Adopted … -
List item
Human medicine European public assessment report (EPAR): Alli (previously Orlistat GSK)
orlistat, Obesity
Date of authorisation: 22/07/2007, Revision: 18, Authorised, Last updated: 06/01/2022Alli (previously Orlistat GSK) Overweight Body … assessment report (EPAR) for Alli. It explains how the The committee … the conditions of use for Alli. What is Alli? Alli is a medicine that contains … -
List item
Meeting with Alliance for Regenerative Medicine
European Medicines Agency, London, UK, 14/12/2017, Last updated: 19/12/2017Meeting with Alliance for Regenerative Medicine … organised at the request of the Alliance for Regenerative Medicines … Documents Minutes - Meeting with Alliance for Regenerative Medicine … -
List item
National expert: Maria Soledad Garcia Penalta, European Medicines Agency (updated)
- Declaration of interests - 41.14 KB | PDF
- Curriculum Vitae - 29.6 KB | PDF
Spain 1. Employer: PAIN Alliance Europe • Start date: 112020 • … Spain 5. Employer: PAE(Pain Alliance Europe) • Start date: 112013 • … Support the work of Pain Alliance Europe (PAE) and provide … -
List item
National expert: Sine Buhl Naess-Schmidt, Danish Medicines Agency (updated)
- Declaration of interests - 42.65 KB | PDF
- Curriculum Vitae - 42.53 KB | PDF
by Nordforsk Nordic Trial Alliance, Danish Regions (Medicin Puljen … -
List item
Human medicine European public assessment report (EPAR): Xenical (updated)
orlistat, Obesity
Date of authorisation: 29/07/1998, Revision: 25, Authorised, Last updated: 10/05/2023centrally authorised medicines Alli (orlistat), Mircera (methoxy … Roche Carolina Inc.: • Alli and Xenical, containing the … obtained with a prescription. Alli was authorised in 2007 and … -
List item
Referral: Orlistat
orlistat, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/02/2012, EC decision date: 24/04/2012, Last updated: 21/12/2012obtained with a prescription. Alli was authorised in 2007 and … side effects. Xenical and Alli are together estimated to … liver failure in people using Alli since it was marketed in … -
List item
Human medicine European public assessment report (EPAR): Cabometyx
cabozantinib (s)-malate, Carcinoma, Renal Cell; Carcinomas, Hepatocellular
Date of authorisation: 09/09/2016,
, Revision: 16, Authorised, Last updated: 05/04/2023
-
List item
Human medicine European public assessment report (EPAR): Sarclisa
Isatuximab, Multiple Myeloma
Date of authorisation: 30/05/2020,
, Revision: 7, Authorised, Last updated: 25/04/2023
-
List item
Human medicine European public assessment report (EPAR): Livmarli (updated)
Maralixibat chloride, Alagille Syndrome
Date of authorisation: 09/12/2022,, 
, 
, Revision: 1, Authorised, Last updated: 25/05/2023
-
List item
Human medicine European public assessment report (EPAR): Mircera
Methoxy polyethylene glycol-epoetin beta, Anemia; Kidney Failure, Chronic
Date of authorisation: 20/07/2007, Revision: 28, Authorised, Last updated: 20/03/2023centrally authorised medicines Alli (orlistat), Mircera (methoxy … Roche Carolina Inc.: • Alli and Xenical, containing the … -
List item
Human medicine European public assessment report (EPAR): Evenity
Romosozumab, Osteoporosis
Date of authorisation: 09/12/2019,, Revision: 3, Authorised, Last updated: 23/02/2023
-
List item
Human medicine European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories) (updated)
6-mercaptopurine monohydrate, Leukemia, Lymphoid
Date of authorisation: 09/03/2012, Revision: 15, Authorised, Last updated: 25/05/2023 -
List item
Human medicine European public assessment report (EPAR): Epclusa
Sofosbuvir, velpatasvir, Hepatitis C, Chronic
Date of authorisation: 06/07/2016,, Revision: 20, Authorised, Last updated: 21/04/2023
-
List item
National expert: Marie Pauline J. Evers, European Medicines Agency (updated)
- Declaration of interests - 41.22 KB | PDF
- Curriculum Vitae - 23.96 KB | PDF
Employer: Dutch Genetic Alliance VSOP • Start date: 062003 • … representative is the European Genetic Alliances Network (EGAN, www.egan.eu … -
List item
Human medicine European public assessment report (EPAR): Tamiflu
oseltamivir, Influenza, Human
Date of authorisation: 20/06/2002, Revision: 42, Authorised, Last updated: 24/03/2023centrally authorised medicines Alli (orlistat), Mircera (methoxy … Roche Carolina Inc.: • Alli and Xenical, containing the … -
List item
Human medicine European public assessment report (EPAR): Xeljanz
Tofacitinib, Arthritis, Rheumatoid
Date of authorisation: 22/03/2017,
Date of refusal: 25/04/2013,
, Revision: 26, Authorised, Last updated: 30/03/2023
-
List item
Human medicine European public assessment report (EPAR): Trisenox (updated)
Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 05/03/2002, Revision: 31, Authorised, Last updated: 25/05/2023 -
List item
Human medicine European public assessment report (EPAR): Rapiscan (updated)
regadenoson, Myocardial Perfusion Imaging
Date of authorisation: 06/09/2010, Revision: 15, Authorised, Last updated: 25/05/2023 -
List item
Human medicine European public assessment report (EPAR): Repatha
Evolocumab, Dyslipidemias; Hypercholesterolemia
Date of authorisation: 17/07/2015, Revision: 24, Authorised, Last updated: 28/04/2023 -
List item
Human medicine European public assessment report (EPAR): Dovprela (previously Pretomanid FGK)
Pretomanid, Tuberculosis, Multidrug-Resistant
Date of authorisation: 31/07/2020,, , 
, Revision: 7, Authorised, Last updated: 24/02/2023
-
List item
National expert: Dimitrios Athanasiou, European Medicines Agency (updated)
- Declaration of interests - 40.83 KB | PDF
- Curriculum Vitae - 21.35 KB | PDF
and Board Member in 95 Rare Alliance Greece and in the Greek Patient … -
List item
Human medicine European public assessment report (EPAR): Breyanzi (updated)
CD19-directed genetically modified autologous cell-based product consisting of purified CD8+ T-cells (CD8+ cells), CD19-directed genetically modified autologous cell-based product consisting of purified CD4+ T cells (CD4+ cells), Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Mediastinal Neoplasms
Date of authorisation: 04/04/2022,, Revision: 1, Authorised, Last updated: 25/05/2023
-
List item
Human medicine European public assessment report (EPAR): Eladynos (updated)
abaloparatide, Osteoporosis, Postmenopausal; Osteoporosis, Revision: 1, Authorised, Last updated: 22/05/2023